Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ENDOMETRIAL NEOPLASMS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01830192
What this trial is testing

REM (Risk Of Endometrial Malignancy)

Who this might be right for
Endometrial Disease
Campus Bio-Medico University 741
Not applicableActive Not RecruitingNCT03285230
What this trial is testing

The French E3N Prospective Cohort Study

Who this might be right for
Breast CancerColo-rectal CancerParkinson Disease+11 more
Institut National de la Santé Et de la Recherche Médicale, France 100,000
Not applicableActive Not RecruitingNCT03776630
What this trial is testing

Exploring the Potential of Novel Biomarkers Based on Plasma microRNAs for a Better Management of Pelvic Gynecologic Tumors

Who this might be right for
Ovarian CancerEndometrial Cancer
Assistance Publique - Hôpitaux de Paris 363
Not applicableStudy completedNCT03722030
What this trial is testing

Telehealth-Based Resistance Training Intervention for Endometrial Cancer Survivors

Who this might be right for
Endometrial Cancer
University of Wisconsin, Madison 40
Not applicableActive Not RecruitingNCT07354087
What this trial is testing

Impact of Molecular Pathological And Clinical Features for Adjuvant Treatment Selection in Endometrial Cancer: Asian Registry

Who this might be right for
Endometrial Cancer
Tata Memorial Hospital 300
Testing effectiveness (Phase 2)Looking for participantsNCT06993844
What this trial is testing

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsAdvanced Breast Cancer
Ensem Therapeutics 233
Not applicableUnknownNCT04438564
What this trial is testing

Immunoassay and Regulation of Traditional Chinese Medicine on Cancer Patients

Who this might be right for
Breast CancerColorectal CancerCancer of Ovary+1 more
China Medical University Hospital 300
Not applicableUnknownNCT05273099
What this trial is testing

Molecular Biomarkers Predicting Early Development of Endometrial Carcinoma

Who this might be right for
Cancer of Endometrium
Università degli Studi di Ferrara 8
Not applicableTemporarily pausedNCT05506800
What this trial is testing

Guangzhou Women's Health Cohort Study (GWHCS)

Who this might be right for
Cervical CancerBreast CancerLung Cancer+6 more
Guangzhou Women and Children's Medical Center 1,000,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07631871
What this trial is testing

An Exploratory Study of Zanidatamab in HER2-positive Advanced Tumor After at Least One Line of Standard Therapy

Who this might be right for
NeoplasmsSolid TumorsHER2 Positive Solid Tumor+7 more
Haihua Yuan 10
Not applicableLooking for participantsNCT06774209
What this trial is testing

Multimodal PET Imaging in the Diagnosis and Treatment of Pelvic Tumors

Who this might be right for
Endometrial Cancer
Peking Union Medical College Hospital 30
Early research (Phase 1)UnknownNCT04460456
What this trial is testing

SBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Solid Tumors

Who this might be right for
HER2 Positive Solid Tumors
Silverback Therapeutics 58
Early research (Phase 1)Ended earlyNCT03924245
What this trial is testing

Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube Cancers

Who this might be right for
Fallopian Tube CancerFallopian Tube CarcinosarcomaFallopian Tube Clear Cell Adenocarcinoma+10 more
Vanderbilt-Ingram Cancer Center 3
Early research (Phase 1)Active Not RecruitingNCT02208375
What this trial is testing

MTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian

Who this might be right for
BRCA1 Mutation CarrierBRCA2 Mutation CarrierEndometrial Adenocarcinoma+13 more
M.D. Anderson Cancer Center 159
Not applicableStudy completedNCT02226302
What this trial is testing

Linking Obesity and Estrogen-responsive Genes in Endometrial Cancer

Who this might be right for
Endometrial Cancer
Queensland Centre for Gynaecological Cancer 16
Not applicableLooking for participantsNCT06619002
What this trial is testing

Implementation of Surgical Safety and Intraoperative Metastasis Identification Through Deep Learning: Multicentric Video Collection for Minimally Invasive Sentinel Lymph Node Dissection in Uterine Malignancies

Who this might be right for
Endometrial CancerCervical CancerDeep Learning+1 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 100
Not applicableLooking for participantsNCT05051722
What this trial is testing

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

Who this might be right for
Endometrial CancerCervical CancerAtypical Endometrial Hyperplasia+3 more
Mayo Clinic 3,110
Testing effectiveness (Phase 2)UnknownNCT03570437
What this trial is testing

Does Cediranib With Paclitaxel, or Cediranib and Olaparib, Treat Advanced Endometrial Cancer Better Than Paclitaxel?

Who this might be right for
CarcinosarcomaEndometrial Neoplasms
University of Manchester 124
Early research (Phase 1)Study completedNCT05858736
What this trial is testing

Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors

Who this might be right for
MelanomaNon Small Cell Lung CancerHead and Neck Squamous Cell Carcinoma+14 more
OncoC4, Inc. 18
Testing effectiveness (Phase 2)Looking for participantsNCT05548296
What this trial is testing

ACR-368 in Endometrial Adenocarcinoma

Who this might be right for
Endometrial Adenocarcinoma
Acrivon Therapeutics 350
Next Page